Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities

In this episode, Marta Boffito, MD, PhD, FRCP, and Jens D. Lundgren, MD, DMSc, address key considerations when evaluating antiretroviral therapy safety and tolerability in aging patients and those with possible cardiometabolic toxicities, including:

• Monitoring for cardiometabolic syndromes (eg, lipid panels, coronary artery calcification scores)
• Approaching antiretroviral-related weight gain in clinical practice
• Interpreting results from RESPOND on cardiovascular risk with integrase strand transfer inhibitors
• Collaborating with other specialties (eg, cardiologists, dietitians) to provide a multidisciplinary approach for managing comorbidities, including prevention and management

Faculty: 

Marta Boffito, MD, PhD, FRCP
Consultant Physician/Professor
HIV/Research
Chelsea and Westminster Hospital
Imperial College London
London, United Kingdom

Jens D. Lundgren, MD, DMSc
Professor
Rigshospital, University of Copenhagen 
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Link to full program:
http://bit.ly/3PM3nYe

Link to downloadable slides: 
http://bit.ly/3WgYycz

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.